CINDY LOEB: Open Payments
NPI 1942889126 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,867 in 163 payments from 19 companies in 2025. Trend: 2023 $1,952 · 2024 $2,741 · 2025 $3,867
Food & beverage: $3,867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $660 |
| Janssen Biotech, Inc. | 11 | $596 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $388 |
| Madrigal Pharmaceuticals | 13 | $386 |
| PFIZER INC. | 18 | $338 |
| Ardelyx, Inc. | 11 | $282 |
| GENZYME CORPORATION | 7 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Aimmune Therapeutics, Inc. | 5 | $123 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, DUPIXENT, IBSRELA, XELJANZ, RINVOQ, SKYRIZI.
Industry payments across SC — which companies pay providers there.
